Downloadable Slidesets

Share

Program Content

Activities

  • BTKi Safety
    BTK Inhibitors for Managing Patients with B-Cell Malignancies: Safety and Optimal Use
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • BTKi in MCL
    Practical Case Discussions: BTK inhibitor Therapy for MCL
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • BTKi in Frontline CLL
    Practical Case Discussions: BTK inhibitor Therapy for Frontline CLL
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • BTKi in Other Types
    BTK Inhibitors in “Other” B-Cell Malignancies
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • BTKi Resistance
    Overcoming BTK Inhibitor Resistance and Combination Strategies
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

Faculty

cover img faculity

Jan A. Burger, MD, PhD

Professor of Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Alexey Danilov, MD

Associate Professor of Medicine
Department of Hematology/Oncology
Knight Cancer Institute
Oregon Health and Science University
Portland, Oregon

cover img faculity

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

cover img faculity

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

ProCE Banner

Supporters

AstraZeneca

BeiGene, Ltd.

Loxo Oncology subsidiary of Eli Lilly